Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older
Gardin, C., Chevret, S., Pautas, C., Turlure, P., Raffoux, E., Thomas, X., Quesnel, B., de Revel, T., de Botton, S., Gachard, N., Renneville, A., Boissel, N., Preudhomme, C., Terre, C., Fenaux, P., BoVolume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.40.3642
Date:
January, 2013
File:
PDF, 184 KB
english, 2013